Last updated: September 12, 2024
Sponsor: Federico II University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Miscarriage
Treatment
Transvaginal ultrasound cervical length screening
Clinical Study ID
NCT02923973
#30/18
Ages 18-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18-50 years of age
Singleton gestations
Women with prior spontaneous preterm birth, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks
Exclusion
Exclusion Criteria:
multiple gestation
Ruptured membranes or fetal structural or chromosomal abnormality at the time ofrandomization
Ballooning of membranes outside the cervix into the vagina at the time ofrandomization
Labor or cerclage in situ at the time of randomization
Study Design
Total Participants: 500
Treatment Group(s): 1
Primary Treatment: Transvaginal ultrasound cervical length screening
Phase:
Study Start date:
June 01, 2018
Estimated Completion Date:
March 01, 2025
Connect with a study center
Gabriele Saccone
Naples, 80100
ItalyActive - Recruiting
University of Pisa
Pisa,
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.